Survival outcomes after DA-R-EPOCH for PMBCL. PFS (A) and OS (B) after treatment with DA-R-EPOCH among patients with PMBCL treated at 2 tertiary cancer centers (cohorts 1 and 2).
Sign In or Create an Account